MarketLens

Log in

Why Did Raymond James Downgrade BridgeBio Pharma

11 hours ago
SHARE THIS ON:

Why Did Raymond James Downgrade BridgeBio Pharma

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News6 days ago

Why Phreesia Stock Got Clocked Today

Phreesia shares faced downward pressure after an analyst downgraded the stock to hold. The firm also slashed its price target by nearly 50%, citing concerns that could weigh on near-term valuation.
Stock News2 weeks ago

BridgeBio Pharma, Inc. (BBIO) Q1 2026 Earnings Call Transcript

BridgeBio Pharma (BBIO) released its Q1 2026 earnings transcript, providing updates on its clinical pipeline and financial position. The disclosure offers investors insight into the company's operatio...
Stock News4 weeks ago

Why Is Guardant Health Stock Falling On Tuesday?

Guardant Health shares fell on Tuesday following the FDA's announcement that it will review AstraZeneca's application for camizestrant. The regulatory update for the breast cancer treatment appears to...
Stock News4 weeks ago

Bridgewater (BWB) Upgraded to Buy: Here's Why

Bridgewater (BWB) was upgraded to a Zacks Rank #2 (Buy) status, reflecting increased analyst optimism regarding the company's future earnings prospects. This improved ranking could potentially drive n...

Breaking News

View All →

Top Headlines

View More →
Stock News1 hour ago

AI Buildout Fuels Record Results for These Companies

Stock News1 hour ago

DuckDuckGo installs are up 30% as users reject being ‘force-fed' Google's AI Search

Stock News1 hour ago

Is AMD Stock an Undervalued Stock to Buy?

Stock News2 hours ago

How a stock market ‘melt-up' could carry the S&P 500 to 8,000 or beyond

Stock News3 hours ago

What Jensen Huang Said That Nobody Noticed